Partner news
News
Partner news
Teneobio Announces Achievement of Milestone Payment as Janssen Advances Phase I Study of Bispecific JNJ-75348780 for the Treatment of NHL and CLL
Read full storyPartner news
Cidara Therapeutics Announces Agreement with Janssen to Develop and Commercialize AVCs for the Prevention and Treatment of Influenza
Read full storyOther news
Amgen to Acquire Rodeo Therapeutics Corporation
Read full storyOther news
Next-generation Radiopharmaceuticals Company POINT Biopharma to list on NASDAQ through merger with Research Alliance Corp. I
Read full storyOther news
Paige Secures Financing from KKR for Total Series C Funding Round of Over $125 Million
Read full storyOther news
FDA Authorizes Cue Health's COVID-19 Test for At-Home and Over The Counter Use
Read full storyOther news
ViaCyte and Gore Expand Collaboration to Develop Novel Membrane and Device Technologies that Enhance Delivery of Cell Replacement Therapies for Diabetes
Read full storyPartner news
Oxford to collaborate with Janssen to map the cellular landscape of immune mediated disorders
Read full storyPartner news
Adicet Bio, Inc. Announces Pricing of $135 Million Public Offering of Common Stock and Concurrent Private Placement
Read full storyJNJ Press releases
Gathering Innovation Strength to Capture New Value Johnson & Johnson is Recognized as the First Foreign-Funded Open Innovation Platform by the Shanghai Municipal Government
Read full storyPartner news
Exonate announces the initiation of Phase Ib/II clinical trial for Diabetic Macular Oedema, as part of its collaboration with Janssen
Read full storyOther news
ViaCyte Appoints Michael Yang President and CEO and Provides Company Update
Read full storyOther news
Paige Announces Series C Funding Round of $100 Million to Accelerate Transformation of Digital Pathology
Read full storyPartner news